Over $15.5M Bet On ModivCare? Check Out These 4 Stocks Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insider trades were noted in four US-listed companies: Akero Therapeutics, ModivCare, TreeHouse Foods, and V.F. Corporation. Akero Therapeutics' Director acquired 25,000 shares at an average price of $42.06, following the company's recent successful SYMMETRY study. ModivCare's Director bought 435,893 shares at an average price of $35.74, despite the company's weaker-than-expected quarterly results. TreeHouse Foods' 10% owner purchased 41,500 shares at an average price of $46.11, after the company reported a 4.1% YoY sales growth. V.F. Corporation's Director bought 40,000 shares at an average price of $19.09, despite the company's wider-than-expected Q1 loss.
August 11, 2023 | 1:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Akero Therapeutics' Director bought 25,000 shares following the company's successful SYMMETRY study.
The insider purchase indicates confidence in the company's prospects, potentially leading to a positive short-term impact on the stock.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
TreeHouse Foods' 10% owner bought 41,500 shares after the company reported a 4.1% YoY sales growth.
The insider purchase, combined with the company's strong sales growth, could lead to a positive short-term impact on the stock.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
NEUTRAL IMPACT
ModivCare's Director bought 435,893 shares despite the company's weaker-than-expected quarterly results.
The insider purchase may signal a belief in the company's long-term prospects, but the recent weak quarterly results could limit short-term gains.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 100
NEUTRAL IMPACT
V.F. Corporation's Director bought 40,000 shares despite the company's wider-than-expected Q1 loss.
The insider purchase may indicate confidence in the company's long-term prospects, but the recent Q1 loss could limit short-term gains.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 100